Physician

Mitchell Howard Folbe, MD

According to 2025 Medicare claims, Mitchell Folbe, MD (NPI: 1255321683) practices medical oncology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MICHIGAN HEALTHCARE PROFESSIONALS PC (NPI: 1295023547; TIN: 451674932) and primary practice location at 48314-1041. Folbe is affiliated with the Honest ACO of Michigan LLC (ACO ID: D0236), participating under the REACH model.

Folbe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 403 traditional Medicare patients, billed 110,939 HCPCS/CPT codes, and received $2,229,629 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 666 prescription claims across 191 beneficiaries totaling $220,576 in drug costs, led by Xarelto (Rivaroxaban). 2021 DME data shows 26 claims. Open Payments data shows 175 records totaling $3,179. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,115,869 to $2,229,629. In contrast, Part D prescription costs have declined steadily, from $1,861,424 to $220,576. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	458	91,133	$1,115,869
2016	432	26,101	$174,767
2017	443	41,489	$719,537
2018	433	49,540	$731,251
2019	461	69,194	$1,033,997
2020	418	83,036	$1,271,212
2021	420	90,379	$1,430,614
2022	406	100,580	$1,744,190
2023	401	96,097	$1,971,334
2024	403	110,939	$2,229,629

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	185	993	$1,861,424
2016	183	1,046	$2,464,990
2017	168	1,069	$2,760,562
2018	180	1,008	$2,060,489
2019	206	1,069	$2,549,214
2020	184	1,081	$3,149,144
2021	204	1,021	$2,462,893
2022	192	787	$1,081,464
2023	191	823	$652,916
2024	191	666	$220,576

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	163	$45,337
2016	N/R	217	$41,491
2017	N/R	46	$11,939
2018	N/R	71	$9,465
2019	N/R	N/R	N/R
2020	N/R	23	$1,891
2021	N/R	26	$1,207
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	48	54	$137
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	120	120	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	259	633	$94
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	49	130	$63
36415	Insertion of needle into vein for collection of blood sample	279	771	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	26	1,050	$18,911
Eliquis	Apixaban	18	870	$16,629
Anastrozole	Anastrozole	101	8,540	$4,612
Hydroxyurea	Hydroxyurea	62	5,294	$2,435
Tamoxifen Citrate	Tamoxifen Citrate	49	4,032	$1,224

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	175	$3,179	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mitchell Howard Folbe, MD?

Tedicare shows public-source Medicare data for Mitchell Howard Folbe, MD (NPI 1255321683), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mitchell Howard Folbe, MD have ACO affiliation data?

Mitchell Howard Folbe, MD is shown with ACO affiliation data for Honest ACO of Michigan LLC (REACH, ACO ID D0236).

What billing organization is linked to Mitchell Howard Folbe, MD?

Mitchell Howard Folbe, MD is linked to MICHIGAN HEALTHCARE PROFESSIONALS PC (billing NPI 1295023547) in the available physician profile data.

Does Mitchell Howard Folbe, MD have Open Payments data?

Mitchell Howard Folbe, MD has 175 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.